0000950170-24-082242.txt : 20240708
0000950170-24-082242.hdr.sgml : 20240708
20240708200125
ACCESSION NUMBER: 0000950170-24-082242
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240708
DATE AS OF CHANGE: 20240708
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Mural Oncology plc
CENTRAL INDEX KEY: 0001971543
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-41837
FILM NUMBER: 241106129
BUSINESS ADDRESS:
STREET 1: 10 EARLSFORT TERRACE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 T380
BUSINESS PHONE: 353 1 905 8020
MAIL ADDRESS:
STREET 1: 10 EARLSFORT TERRACE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 T380
FORMER COMPANY:
FORMER CONFORMED NAME: Mural Oncology Ltd
DATE OF NAME CHANGE: 20230403
FORMER COMPANY:
FORMER CONFORMED NAME: Pistachiovale Ltd
DATE OF NAME CHANGE: 20230329
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Loew Caroline
CENTRAL INDEX KEY: 0001989488
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: MURAL ONCOLOGY LTD.
STREET 2: 10 EARLSFORT TERRACE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 T380
144
1
primary_doc.xml
144
0001989488
XXXXXXXX
LIVE
0001971543
Mural Oncology plc
001-41837
10 Earlsfort Terrace
Dublin 2
L2
D02 T380
353-1-905-8020
Loew Caroline
Officer
Director
Ordinary Shares
MorganStanley Private Bank
Harborside 2
200 Hudson Street, Suite 501
Jersey City
NJ
07311
12531
36469.05
16923878
07/08/2024
NASDAQ
Ordinary Shares
07/05/2024
Restricted Stock Units
Issuer
N
12531
07/05/2024
Equity Compensation
Y
Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 14, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement that includes a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on March 27, 2024, and the sale does not represent a discretionary trade by the Reporting Person.
07/08/2024
/s/ Caroline Loew